CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Lumefantrine

苯芴醇 杂质对照品Lumefantrine Impurities

32 个杂质条目32 impurity entries

本页汇总 苯芴醇 的 32 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 32 impurity reference standards of Lumefantrine. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 苯芴醇(Lumefantrine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine
    Malaria journal · 2011 · Verbeken M et al.  ·  PMID 21356068  ·  DOI
  2. 杂质研究Impurity studiesA rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products
    Malaria journal · 2013 · Suleman S et al.  ·  PMID 23631682  ·  DOI
  3. 杂质研究Impurity studiesGas chromatographic method for the determination of lumefantrine in antimalarial finished pharmaceutical products
    Journal of food and drug analysis · 2015 · Suleman S et al.  ·  PMID 28911715  ·  DOI
  4. 分析方法Analytical MethodsDevelopment of the RP-HPLC Method for Simultaneous Determination and Quantification of Artemether and Lumefantrine in Fixed-Dose Combination Pharmaceutical Dosage Forms
    Advances in pharmacological and pharmaceutical sciences · 2024 · Nyarko S et al.  ·  PMID 38356988  ·  DOI
  5. 分析方法Analytical MethodsMethod development and validation for simultaneous determination of lumefantrine and its major metabolite, desbutyl lumefantrine in human plasma using RP-HPLC/UV detection
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2014 · Khuda F et al.  ·  PMID 24316521  ·  DOI

苯芴醇 —— 原料药与杂质对照品Lumefantrine — drug substance & impurities

共 33 个条目(含原料药本体)33 items incl. the drug substance
Lumefantrine structure
原料药 APIAPI
苯芴醇Lumefantrine
Lumefantrine
CAS No.82186-77-4
Chemical FormulaC30H32Cl3NO
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 1 structure
1
苯芴醇杂质1Lumefantrine Impurity 1
Lumefantrine Impurity 1
CAS No.1331642-68-2
Chemical FormulaC30H32Cl3NO
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 2 structure
2
苯芴醇杂质2Lumefantrine Impurity 2
Lumefantrine Impurity 2
CAS No.1795129-61-1
Chemical FormulaC44H24Cl6O2
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 3 structure
3
苯芴醇杂质3Lumefantrine Impurity 3
Lumefantrine Impurity 3
CAS No.1795128-25-4
Chemical FormulaC44H24Cl6O2
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 4 (Lumefantrine E-isomer) structure
4
苯芴醇杂质4 (苯芴醇E-异构体)Lumefantrine Impurity 4 (Lumefantrine E-isomer)
Lumefantrine Impurity 4 (Lumefantrine E-isomer)
CAS No.1456736-33-6
Chemical FormulaC30H32Cl3NO
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 5 structure
5
苯芴醇杂质5Lumefantrine Impurity 5
Lumefantrine Impurity 5
CAS No.1582279-20-6
Chemical FormulaC19H19Cl2NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 7 structure
7
苯芴醇杂质7Lumefantrine Impurity 7
Lumefantrine Impurity 7
CAS No.4364-35-6
Chemical FormulaC20H11Cl3
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 9 (Desbutyl Lumefantrine) structure
9
苯芴醇杂质9(去丁基苯芴醇)Lumefantrine Impurity 9 (Desbutyl Lumefantrine)
Lumefantrine Impurity 9 (Desbutyl Lumefantrine)
CAS No.355841-11-1
Chemical FormulaC26H24Cl3NO
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 10 structure
10
苯芴醇杂质10Lumefantrine Impurity 10
Lumefantrine Impurity 10
CAS No.53221-25-3
Chemical FormulaC23H27Cl2NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 11 structure
11
苯芴醇杂质11Lumefantrine Impurity 11
Lumefantrine Impurity 11
CAS No.53221-14-0
Chemical FormulaC15H10Cl2O
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 12 structure
12
苯芴醇杂质12Lumefantrine Impurity 12
Lumefantrine Impurity 12
CAS No.69759-61-1
Chemical FormulaC23H29Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 13 structure
13
苯芴醇杂质13Lumefantrine Impurity 13
Lumefantrine Impurity 13
CAS No.252990-29-7
Chemical FormulaC22H13Cl3O
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 14 structure
14
苯芴醇杂质14Lumefantrine Impurity 14
Lumefantrine Impurity 14
CAS No.7012-16-0
Chemical FormulaC13H8Cl2
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 15 structure
15
苯芴醇杂质15Lumefantrine Impurity 15
Lumefantrine Impurity 15
CAS No.2170653-95-7
Chemical FormulaC30H32Cl3NO
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 16 structure
16
苯芴醇杂质16Lumefantrine Impurity 16
Lumefantrine Impurity 16
CAS No.2170653-94-6
Chemical FormulaC23H29Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 17 structure
17
苯芴醇杂质17Lumefantrine Impurity 17
Lumefantrine Impurity 17
CAS No.2523-44-6
Chemical FormulaC13H9Cl
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 19 structure
19
苯芴醇杂质19Lumefantrine Impurity 19
Lumefantrine Impurity 19
CAS No.153-78-6
Chemical FormulaC13H11N
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 20 structure
20
苯芴醇杂质20Lumefantrine Impurity 20
Lumefantrine Impurity 20
CAS No.607-57-8
Chemical FormulaC13H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 21 structure
21
苯芴醇杂质21Lumefantrine Impurity 21
Lumefantrine Impurity 21
CAS No.345925-36-2
Chemical FormulaC18H20N2
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 22 structure
22
苯芴醇杂质22Lumefantrine Impurity 22
Lumefantrine Impurity 22
CAS No.2464-37-1
Chemical FormulaC14H9ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 23 structure
23
苯芴醇杂质23Lumefantrine Impurity 23
Lumefantrine Impurity 23
CAS No.2536-31-4
Chemical FormulaC15H11ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 24 structure
24
苯芴醇杂质24Lumefantrine Impurity 24
Lumefantrine Impurity 24
CAS No.154479-90-0
Chemical FormulaC16H13ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 25 structure
25
苯芴醇杂质25Lumefantrine Impurity 25
Lumefantrine Impurity 25
CAS No.1689-64-1
Chemical FormulaC13H10O
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 26 structure
26
苯芴醇杂质26Lumefantrine Impurity 26
Lumefantrine Impurity 26
CAS No.252029-00-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 27 structure
27
苯芴醇杂质27Lumefantrine Impurity 27
Lumefantrine Impurity 27
CAS No.47758-37-2
Chemical FormulaC31H26O4
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 29 (Mixture of E/Z-isomers) structure
29
苯芴醇杂质29 (混合E/Z构型)Lumefantrine Impurity 29 (Mixture of E/Z-isomers)
Lumefantrine Impurity 29 (Mixture of E/Z-isomers)
CAS No.252990-19-5
Chemical FormulaC26H24Cl3NO
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 30 structure
30
苯芴醇杂质30Lumefantrine Impurity 30
Lumefantrine Impurity 30
CAS No.287493-16-7
Chemical FormulaC17H16BrI
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 31 structure
31
苯芴醇杂质31Lumefantrine Impurity 31
Lumefantrine Impurity 31
CAS No.60550-84-7
Chemical FormulaC14H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 32 structure
32
苯芴醇杂质32Lumefantrine Impurity 32
Lumefantrine Impurity 32
CAS No.3023-49-2
Chemical FormulaC15H14O
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 33 (Mixture of E/Z-isomers) structure
33
苯芴醇杂质33 (混合E/Z构型)Lumefantrine Impurity 33 (Mixture of E/Z-isomers)
Lumefantrine Impurity 33 (Mixture of E/Z-isomers)
CAS No.204133-10-8
Chemical FormulaC30H32Cl3NO
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 36 structure
36
苯芴醇杂质36Lumefantrine Impurity 36
Lumefantrine Impurity 36
CAS No.934748-28-4
Chemical FormulaC13H8Cl2
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 37 structure
37
苯芴醇杂质37Lumefantrine Impurity 37
Lumefantrine Impurity 37
CAS No.7061-81-6
Chemical FormulaC13H7Cl3
Purity>95%询价On request
10mg25mg50mg100mg
Lumefantrine Impurity 4-d18 (Lumefantrine E-isomer) structure
4-D18
苯芴醇杂质4-d18 (苯芴醇E-异构体)Lumefantrine Impurity 4-d18 (Lumefantrine E-isomer)
Lumefantrine Impurity 4-d18 (Lumefantrine E-isomer)
CAS No.2734919-55-0
Chemical FormulaC30H14D18Cl3NO
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

苯芴醇 —— 研究文献与合成路线Lumefantrine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 苯芴醇 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Lumefantrine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine
    Verbeken M, Suleman S, Baert B, et al. · Malaria journal · 2011 · 被引 13cited 13
  2. Development of the RP-HPLC Method for Simultaneous Determination and Quantification of Artemether and Lumefantrine in Fixed-Dose Combination Pharmaceutical Dosage Forms
    Nyarko S, Ofori-Kwakye K, Johnson R, et al. · Advances in pharmacological and pharmaceutical sciences · 2024 · 被引 2cited 2
  3. HPLC-UV method for simultaneous quantitation of artemether and lumefantrine in fixed dose combination orodispersible tablet formulation
    Habib R, Shoaib MH, Ahmed FR, et al. · Pakistan journal of pharmaceutical sciences · 2020 · 被引 1cited 1
  4. Comparison of HPLC, UV spectrophotometry and potentiometric titration methods for the determination of lumefantrine in pharmaceutical products
    da Costa César I, Nogueira FH, Pianetti GA · Journal of pharmaceutical and biomedical analysis · 2008 · 被引 5cited 5
  5. Gas chromatographic method for the determination of lumefantrine in antimalarial finished pharmaceutical products
    Suleman S, Verheust Y, Dumoulin A, et al. · Journal of food and drug analysis · 2015 · 被引 2cited 2

合成与制备工艺专利Synthesis & process patents

  1. SOFT CAPSULAR PREPARATION OF ARTEMETHER AND LUMEFANTRINE AND PROCESS TO MANUFACTURE SAME
    JOYENDU JAGADINDU CHAUDHURI · 公开号 WO2011141935WO2011141935 · 2011
  2. POLYMORPHIC FORM I OF LUMEFANTRINE AND PROCESSES FOR ITS PREPARATION
    DE Shantanu, RAFEEQ Mohammad, SATHYANARAYANA Swargam · 公开号 WO2006117616WO2006117616 · 2006

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

苯芴醇 杂质谱研究要点Lumefantrine — impurity profiling notes

下面这些是拿到 苯芴醇 的 33 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 33 impurity entries for Lumefantrine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances